The Study
Microcystin-LR drives hepatic meta-inflammation and insulin resistance by hijacking the PP2A-JNK signaling axis.
This study showed that a poison in dirty water can make mouse livers sick and stop them from responding to insulin, but it didn't test this in people. So we know it might happen in mice, but we don't know if it happens the same way in humans.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
A poison from algae in lakes (MC-LR) tricks the liver into thinking it’s under attack, causing it to flood the body with inflammation signals that block insulin from working.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 516 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this shows a common environmental toxin can directly cause type 2 diabetes-like symptoms by disrupting a key liver signaling pathway.
- 2Mice given MC-LR for 6 weeks had high blood sugar, high insulin, and inflamed livers; blocking JNK fixed both the inflammation and blood sugar.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
International immunopharmacology
Year
2025
Authors
Zhengwang Wen, Ya Zhang, Ming Luo, Huanjuan Yan, Haibin Tong, Maoping Chu, Longteng Jin
Related Content
Claims (6)
Persistent inflammation reduces the liver's ability to respond to insulin, leading to increased blood sugar and fat buildup in the liver.
During exposure to microcystin-LR, activation of JNK increases liver inflammation driven by NF-κB, which in turn worsens insulin resistance through a self-reinforcing biological cycle.
In mice, exposure to microcystin-LR triggers activation of the NF-κB inflammatory pathway and elevates liver production of TNF-α, IL-1β, and IL-6, which are associated with insulin resistance.
Chronic exposure to microcystin-LR at doses of 2.5–20 μg/kg in mice increases liver inflammation markers TNF-α, IL-1β, and IL-6, disrupts insulin signaling via JNK-mediated phosphorylation of IRS-1, and results in systemic insulin resistance and glucose intolerance.
Blocking the JNK protein in mice exposed to microcystin-LR reduces liver inflammation and returns normal insulin function.
Microcystin-LR blocks protein phosphatase 2A in mouse liver, which leads to prolonged activation of JNK and the activation of pathways that promote inflammation and insulin resistance.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.